Evaluating antimicrobial stewardship strategies and capacity building through participatory action research and a network approach in Vietnam

通过越南的参与行动研究和网络方法评估抗菌药物管理策略和能力建设

基本信息

  • 批准号:
    MR/Y004701/1
  • 负责人:
  • 金额:
    $ 137.07万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2024
  • 资助国家:
    英国
  • 起止时间:
    2024 至 无数据
  • 项目状态:
    未结题

项目摘要

In Vietnam, surveillance data showed alarmingly high and increasing drug-resistant proportions of important pathogens in hospitals. Antimicrobial stewardship (AMS) has been an important national strategy to improve antibiotic use, however, implementation has been slow at resource-limited hospitals due to lack of resources, skills and capacity. These include district hospitals, the first-point of hospitalization in the public healthcare system where first intravenous antibiotics are usually given empirically in the absence of microbiology lab services. Connecting with provincial-level hospitals through AMS networks is therefore a potential approach to support district hospitals in accessing external available resources for AMS implementation. In this proposed four-year research project, Oxford University Clinical Research Unit Vietnam (OUCRU) and National Hospital for Tropical Diseases will work with two hospital networks in a participatory action research approach to 1) to evaluate the effectiveness, costs and implementation outcomes of AMS programmes delivered through the two local networks, 2) to develop staff capacity in provincial and district hospitals in AMS implementation through participatory action research and network involvement, and 3) to explore opportunities for and contextual factors to support effective implementation of AMS programmes in these AMS hospital networks. Each hospital network will consist of one provincial hospital and five connecting district hospitals identified based on our previous research and the commitment of hospital leadership and AMS staff. Hospital AMS staff (participants) will be involved in an iterative reflective cycle where they will collect and analyse data and determine actions and interventions to implement, observe the process, and reflect and evaluate the outcomes to inform continuing actions. The research team will train hospital staff on AMS related skills and research methods to collect and analyse data, assess and identify interventions, develop and evaluate the implementation. Hospital staff will use evidence and guidance from national guidelines and World Health Organisation's toolkit to identify possible interventions and make hospital-specific action plans contextualized to their local conditions. Results and learning experience will be shared and discussed in regular hospital team meetings and network meetings facilitated by the researchers. We will use a mixed methods design throughout the research including staff survey, interviews and focus group discussions to understand the process, assess implementation aspects including costs, feasibility, acceptability, sustainability and scalability, and explore opportunities and contextual factors for AMS implementation based on the network approach. Longitudinal routine data will be extracted from hospital information systems to evaluate co-primary outcome measures of antibiotic use and clinical outcomes (in-hospital mortality and length of stay). We will also conduct a survey of 2000 patients in all hospitals at two time points, before and 12 months after implementation started, to investigate the potential impact of AMS on colonization of drug-resistant bacteria. Evidence generated from this research will be important for policy makers and hospitals in resource-limited settings like Vietnam in developing and implementing locally adapted AMS programmes. This research will also build the capacity and ownership of local hospitals and their staff in assessing, planning, implementing and evaluating their AMS interventions, and increase the capacity of research staff in implementation science and engaging local partners through the participatory action research process. Local AMS networks will be developed and strengthened to increase resource mobilization, motivation and participation of hospitals in the implementation.
在越南,监测数据显示,医院中重要病原体的耐药率高得惊人,而且还在不断上升。抗菌药物管理(AMS)已成为改善抗生素使用的一项重要的国家战略,然而,由于缺乏资源、技能和能力,资源有限的医院实施缓慢。这些医院包括地区医院,这是公共医疗体系中的第一个住院点,在那里,第一批静脉注射抗生素通常是在缺乏微生物实验室服务的情况下凭经验给予的。因此,通过AMS网络与省级医院连接是支持地区医院获取AMS实施的外部可用资源的一种潜在方法。在这个拟议的为期四年的研究项目中,牛津大学越南临床研究部(OUCRU)和越南国家热带病医院将以参与式行动研究方法与两家医院网络合作,以1)评估通过这两个地方网络交付的AMS方案的有效性、成本和实施结果,2)通过参与性行动研究和网络参与,发展省级和地区医院在AMS实施中的工作人员能力,以及3)探索机会和背景因素,以支持在这些AMS医院网络中有效地实施AMS方案。每个医院网络将由一家省级医院和五家相连的地区医院组成,这是根据我们之前的研究以及医院领导层和AMS工作人员的承诺确定的。医院AMS工作人员(参与者)将参与一个反复的反思周期,他们将收集和分析数据,确定实施的行动和干预措施,观察过程,并反映和评估结果,以便为持续行动提供信息。研究小组将培训医院工作人员与AMS相关的技能和研究方法,以收集和分析数据,评估和确定干预措施,制定和评估实施情况。医院工作人员将使用国家指南和世界卫生组织工具包中的证据和指导,以确定可能的干预措施,并根据当地情况制定医院具体行动计划。研究人员将在定期的医院团队会议和网络会议上分享和讨论成果和学习经验。我们将在整个研究过程中使用混合方法设计,包括工作人员调查、访谈和焦点小组讨论,以了解过程,评估实施方面,包括成本、可行性、可接受性、可持续性和可扩展性,并探索基于网络方法实施AMS的机会和背景因素。将从医院信息系统中提取纵向常规数据,以评估抗生素使用和临床结果(住院死亡率和住院时间)的共同主要结果衡量标准。我们亦会在实施前及实施后12个月的两个时间点,向所有医院的2 000名病人进行调查,以研究AMS对抗药性细菌定植的潜在影响。这项研究产生的证据将对政策制定者和越南等资源有限地区的医院在制定和实施适应当地情况的AMS计划方面具有重要意义。这项研究还将建设当地医院及其工作人员在评估、规划、实施和评估其AMS干预措施方面的能力和自主权,并通过参与性行动研究过程提高研究人员在实施科学和参与当地合作伙伴方面的能力。将发展和加强地方AMS网络,以增加资源调动、动力和医院参与实施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huong Vu其他文献

Corporate sensitivity to sovereign credit distress: the mitigating effects of financial flexibility
企业对主权信用困境的敏感性:财务灵活性的缓解效应
  • DOI:
    10.1080/1351847x.2024.2332718
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Huong Vu;Patrycja Klusak;Shee;Rasha Alsakka
  • 通讯作者:
    Rasha Alsakka
Does competition improve sovereign credit rating quality?
竞争会提高主权信用评级质量吗?
Correction: Gender modified association of oral health indicators with oral health-related quality of life among Korean elders
  • DOI:
    10.1186/s12903-022-02241-y
  • 发表时间:
    2022-05-26
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Huong Vu;Phuc Thi-Duy Vo;Hyun-Duck Kim
  • 通讯作者:
    Hyun-Duck Kim
First-mover Disadvantage: The Sovereign Ratings Mousetrap
先发劣势:主权评级捕鼠器
Differences of opinion in sovereign credit signals during the European crisis
  • DOI:
    10.1080/1351847x.2016.1177565
  • 发表时间:
    2017-01-01
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Alsakka, Rasha;ap Gwilym, Owain;Huong Vu
  • 通讯作者:
    Huong Vu

Huong Vu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Canadian antibiotic prescribing feedback initiative: Building a national framework to combat antimicrobial resistance in primary care (CANBuild-AMR)
加拿大抗生素处方反馈倡议:建立国家框架以应对初级保健中的抗菌药物耐药性 (CANBuild-AMR)
  • 批准号:
    487020
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
Efficient Facility Feedback of Existing Culture Testing is Able to Mitigate Resistance (EFFECT-AMR)
现有培养测试的有效设施反馈能够减轻耐药性 (EFFECT-AMR)
  • 批准号:
    478247
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
一项实用的随机试验,旨在评估同行比较反馈信对医院医生抗菌药物使用的影响
  • 批准号:
    483302
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
一项实用的随机试验,旨在评估同行比较反馈信对医院医生抗菌药物使用的影响
  • 批准号:
    490409
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
Developing and assessing the utility of a digital dashboard for surveillance of antimicrobial use in Nova Scotia
开发和评估用于监测新斯科舍省抗菌药物使用情况的数字仪表板的实用性
  • 批准号:
    478077
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
Promoting Optimal Treatment for Community-Acquired Pneumonia in Emergency Rooms (PIONEERS): a multicentre randomized controlled trial
促进急诊室社区获得性肺炎的最佳治疗 (PIONEERS):一项多中心随机对照试验
  • 批准号:
    488217
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
Population-based study to determine the appropriateness and determinants of antibiotic use in primary care for migrants in Canada using administrative data: from data science to policy and action
基于人群的研究,利用行政数据确定加拿大移民初级保健中抗生素使用的适当性和决定因素:从数据科学到政策和行动
  • 批准号:
    483093
  • 财政年份:
    2023
  • 资助金额:
    $ 137.07万
  • 项目类别:
    Operating Grants
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
移动医疗工具可改善孟加拉国乡村医生的抗生素管理
  • 批准号:
    10527016
  • 财政年份:
    2022
  • 资助金额:
    $ 137.07万
  • 项目类别:
Competency-based training modules for antimicrobial stewardship and infection prevention in veterinary and veterinary nursing curricula
兽医和兽医护理课程中抗菌药物管理和感染预防的基于能力的培训模块
  • 批准号:
    10686964
  • 财政年份:
    2022
  • 资助金额:
    $ 137.07万
  • 项目类别:
Leveraging inpatient antimicrobial stewardship infrastructure to improve antimicrobial-prescribing at hospital discharge
利用住院患者抗菌药物管理基础设施改善出院时的抗菌药物处方
  • 批准号:
    10421218
  • 财政年份:
    2022
  • 资助金额:
    $ 137.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了